These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 20110036

  • 1. Pharmacokinetics of ciclesonide and desisobutyryl ciclesonide after administration via aqueous nasal spray or hydrofluoroalkane nasal aerosol compared with orally inhaled ciclesonide: an open-label, single-dose, three-period crossover study in healthy volunteers.
    Nave R, Herzog R, Laurent A, Wingertzahn MA.
    Clin Ther; 2009 Dec; 31(12):2988-99. PubMed ID: 20110036
    [Abstract] [Full Text] [Related]

  • 2. An investigation of the pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol in healthy subjects and subjects with perennial allergic rhinitis.
    Ratner P, Wingertzahn MA, Herzog R, Huang H, Desai SY, Maier G, Nave R.
    Pulm Pharmacol Ther; 2011 Aug; 24(4):426-33. PubMed ID: 21501692
    [Abstract] [Full Text] [Related]

  • 3. Equivalent pharmacokinetics of the active metabolite of ciclesonide with and without use of the AeroChamber Plus spacer for inhalation.
    Drollmann A, Nave R, Steinijans VW, Baumgärtner E, Bethke TD.
    Clin Pharmacokinet; 2006 Aug; 45(7):729-36. PubMed ID: 16802853
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol, 80 or 160 μg once daily, for the treatment of seasonal allergic rhinitis.
    Ratner P, Jacobs R, Mohar D, Huang H, Desai SY, Hinkle J.
    Ann Allergy Asthma Immunol; 2010 Dec; 105(6):471-9. PubMed ID: 21130386
    [Abstract] [Full Text] [Related]

  • 5. Nasal deposition of ciclesonide nasal aerosol and mometasone aqueous nasal spray in allergic rhinitis patients.
    Emanuel IA, Blaiss MS, Meltzer EO, Evans P, Connor A.
    Am J Rhinol Allergy; 2014 Dec; 28(2):117-21. PubMed ID: 24598007
    [Abstract] [Full Text] [Related]

  • 6. High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma.
    Newman S, Salmon A, Nave R, Drollmann A.
    Respir Med; 2006 Mar; 100(3):375-84. PubMed ID: 16275052
    [Abstract] [Full Text] [Related]

  • 7. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects.
    Nave R, Zech K, Bethke TD.
    Eur J Clin Pharmacol; 2005 May; 61(3):203-8. PubMed ID: 15824911
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treatment of seasonal allergic rhinitis.
    LaForce C, van Bavel J, Meltzer EO, Wingertzahn MA.
    Ann Allergy Asthma Immunol; 2009 Aug; 103(2):166-73. PubMed ID: 19739431
    [Abstract] [Full Text] [Related]

  • 9. Deposition and metabolism of inhaled ciclesonide in the human lung.
    Nave R, Watz H, Hoffmann H, Boss H, Magnussen H.
    Eur Respir J; 2010 Nov; 36(5):1113-9. PubMed ID: 20351025
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma.
    Richter K, Kanniess F, Biberger C, Nave R, Magnussen H.
    J Clin Pharmacol; 2005 Feb; 45(2):146-52. PubMed ID: 15647406
    [Abstract] [Full Text] [Related]

  • 11. A study of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol in patients with seasonal allergic rhinitis from mountain cedar pollen.
    Ratner PH, Andrews C, Martin B, Howland W, Desai SY, Huang H, Hinkle J, Bode F.
    Allergy Asthma Proc; 2012 Feb; 33(1):27-35. PubMed ID: 22370531
    [Abstract] [Full Text] [Related]

  • 12. Effect of coadministered ketoconazole, a strong cytochrome P450 3A4 enzyme inhibitor, on the pharmacokinetics of ciclesonide and its active metabolite desisobutyryl-ciclesonide.
    Böhmer GM, Drollmann A, Gleiter CH, Nave R.
    Clin Pharmacokinet; 2008 Feb; 47(5):343-9. PubMed ID: 18399715
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetic profile of beclomethasone dipropionate hydrofluoroalkane after intranasal administration versus oral inhalation in healthy subjects: results of a single-dose, randomized, open-label, 3-period crossover study.
    Ratner PH, Melchior A, Dunbar SA, Tantry SK, Dorinsky PM.
    Clin Ther; 2012 Jun; 34(6):1422-31. PubMed ID: 22621776
    [Abstract] [Full Text] [Related]

  • 14. Repeated-dose pharmacokinetics of inhaled ciclesonide (CIC-HFA) in Japanese children with bronchial asthma: a phase I study.
    Teramoto T, Matsui E, Fukao T, Sakai K, Yonezawa H, Kato Z, Ohnishi H, Kaneko H, Kondo N, Azuma J, Nishima S.
    Allergol Int; 2012 Dec; 61(4):619-24. PubMed ID: 23000724
    [Abstract] [Full Text] [Related]

  • 15. Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers.
    Leach CL, Bethke TD, Boudreau RJ, Hasselquist BE, Drollmann A, Davidson P, Wurst W.
    J Aerosol Med; 2006 Dec; 19(2):117-26. PubMed ID: 16796536
    [Abstract] [Full Text] [Related]

  • 16. Uptake and metabolism of ciclesonide and retention of desisobutyryl-ciclesonide for up to 24 hours in rabbit nasal mucosa.
    Sato H, Nave R, Nonaka T, Yoshihisa N, Atsuhiro N, Mochizuki T, Takahama S, Kondo S, Wingertzahn M.
    BMC Pharmacol; 2007 Jun 06; 7():7. PubMed ID: 17553148
    [Abstract] [Full Text] [Related]

  • 17. Ciclesonide nasal spray: in allergic rhinitis.
    Dhillon S, Wagstaff AJ.
    Drugs; 2008 Jun 06; 68(6):875-83. PubMed ID: 18416590
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic disposition of inhaled ciclesonide and its metabolite desisobutyryl-ciclesonide in healthy subjects and patients with asthma are similar.
    Nave R, Gunawardena KA, Zech K, Bethke TD.
    Int J Clin Pharmacol Ther; 2006 Jan 06; 44(1):1-7. PubMed ID: 16425964
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R, Bethke TD, van Marle SP, Zech K.
    Clin Pharmacokinet; 2004 Jan 06; 43(7):479-86. PubMed ID: 15139796
    [Abstract] [Full Text] [Related]

  • 20. A patient preference and satisfaction study of ciclesonide nasal aerosol and mometasone furoate aqueous nasal spray in patients with perennial allergic rhinitis.
    Berger WE, Prenner B, Turner R, Meltzer EO.
    Allergy Asthma Proc; 2013 Jan 06; 34(6):542-50. PubMed ID: 24169063
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.